BAXTER HLTHCARE CORP Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?
BAXTER HLTHCARE CORP has sixty-eight approved drugs.
There are twenty-one US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.
There are eleven patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and thirty-seven supplementary protection certificates in fifteen countries.
Summary for BAXTER HLTHCARE CORP
International Patents: | 11 |
US Patents: | 21 |
Tradenames: | 80 |
Ingredients: | 54 |
NDAs: | 68 |
Drugs and US Patents for BAXTER HLTHCARE CORP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | NOURESS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 212535-001 | Dec 13, 2019 | DISCN | Yes | No | 10,702,490 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Baxter Hlthcare Corp | BUTORPHANOL TARTRATE PRESERVATIVE FREE | butorphanol tartrate | INJECTABLE;INJECTION | 075695-001 | Oct 23, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Baxter Hlthcare Corp | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 218878-001 | Sep 24, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Baxter Hlthcare Corp | NOURESS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 212535-001 | Dec 13, 2019 | DISCN | Yes | No | 10,653,719 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAXTER HLTHCARE CORP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-002 | Feb 24, 1998 | 6,900,184 | ⤷ Sign Up |
Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-001 | Feb 24, 1998 | 7,915,229 | ⤷ Sign Up |
Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-001 | Feb 24, 1998 | 6,900,184 | ⤷ Sign Up |
Baxter Hlthcare Corp | CLINOLIPID 20% | olive oil; soybean oil | EMULSION;INTRAVENOUS | 204508-001 | Oct 3, 2013 | 5,840,757 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BAXTER HLTHCARE CORP Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112022015170 | ⤷ Sign Up |
Australia | 2021233893 | ⤷ Sign Up |
Canada | 3174640 | ⤷ Sign Up |
European Patent Office | 4117625 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BAXTER HLTHCARE CORP Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2957286 | 6/2019 | Austria | ⤷ Sign Up | PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721 |
0166287 | 96C0032 | Belgium | ⤷ Sign Up | PRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506 |
1304992 | C01304992/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
2957286 | SPC/GB19/003 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTERED: UK EU/1/17/1179/001(NI) 20170721; UK EU/1/17/1179/002(NI) 20170721; UK EU/1/17/1179/003(NI) 20170721; UK EU/1/17/1179/004(NI) 20170721; UK EU/1/17/1179/005(NI) 20170721; UK EU/1/17/1179/006(NI) 20170721; UK EU/1/17/1179/007(NI) 20170721; UK EU/1/17/1179/008(NI) 20170721; UK EU/1/17/1179/009(NI) 20170721; UK PLGB 50784/0002-0001 20170721; UK PLGB 50784/0003-0001 20170721; UK PLGB 50784/0004-0001 20170721 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.